Therefore, we used immunohistochemical and qRT-PCR analyses to determine whether NCC is expressed in calcified vessels of CKD-MBD rats and whether this expression was affected by the antihypertensive treatments. This evidence concerns the gene SLC12A3 and chronic kidney disease.